title: The rate, risk factors, and outcome of fungal peritonitis in CAPD patients: experience in Turkey.
authors.forename: H
authors.initials: H
authors.lastname: Taşkapan
authors.forename: C
authors.initials: C
authors.lastname: Ozener
authors.forename: K
authors.initials: K
authors.lastname: Ateş
authors.forename: F
authors.initials: F
authors.lastname: Akçiçek
authors.forename: M
authors.initials: M
authors.lastname: Yavuz
authors.forename: M E
authors.initials: ME
authors.lastname: Yilmaz
authors.forename: R
authors.initials: R
authors.lastname: Ataman
authors.forename: S
authors.initials: S
authors.lastname: Bozfakioglu
authors.forename: T
authors.initials: T
authors.lastname: Camsari
authors.forename: F F
authors.initials: FF
authors.lastname: Ersoy
authors.forename: I
authors.initials: I
authors.lastname: Karayaylali
authors.forename: T
authors.initials: T
authors.lastname: Akpolat
authors.forename: C
authors.initials: C
authors.lastname: Utaş
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000379:methods; D010538:Peritonitis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D012189:Retrospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology
chemical_list: D000935:Antifungal Agents